Abirami Seetharaman

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 13, 2025
Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer.

Inemai Ezhil, Abirami Seetharaman, Rahul Kanumuri

|Feb 24, 2024
Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Abirami Seetharaman, Vasanth Christopher, Hemavathi Dhandapani

|Apr 28, 2021
Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro.

Hemavathi Dhandapani, Abirami Seetharaman, Hascitha Jayakumar

Pageof 1

Frequent Collaborators

2 joint publications

Hemavathi Dhandapani

1 joint publications

Hascitha Jayakumar

1 joint publications

Selvaluxmy Ganeshrajah

1 joint publications

Shirley Sunder Singh